Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics -> Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Protocol Plug-and-play starting point Manufacturing Automation

Protocol: PAT Model Qualification and Real-Time Release Equivalence

A plug-and-play qualification protocol for a process analytical technology (PAT) chemometric model intended to support in-process control or real-time release testing: calibration data set, accuracy/precision/specificity test cases, applicability-domain limits, negative-path challenges, and equivalence to the reference laboratory method, with a filled specimen.

Document type: Protocol

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use qualification protocol for a process analytical technology (PAT) system whose chemometric model output will support an in-process control decision or replace a laboratory test as part of real-time release testing (RTRT). Replace every <<FILL: ...>> placeholder, set your own document numbers and dates, and route it through your normal validation review and approval. A worked filled specimen follows. Verify each cited reference against the current source before you rely on it. This content is general educational reference, not legal or regulatory advice.

Approval page

RoleNameSignatureDate
Protocol author<<FILL>>
Process engineering / PAT lead<<FILL>>
Analytical / QC lead (reference method owner)<<FILL>>
Quality Assurance<<FILL>>

1. Objective

To demonstrate that the PAT system <<FILL: system/probe name and ID>>, using chemometric model <<FILL: model name and version>>, produces results that are accurate, precise, specific, and equivalent to the qualified reference method <<FILL: reference method ID>> across the intended operating range, and that the model’s applicability domain and failure detection reliably flag conditions outside that range, before the system is used to support <<FILL: in-process control / RTRT disposition of SPECIFIC TEST>>.

2. Scope

This protocol applies to the PAT hardware (the probe or sensor), the chemometric model that converts its raw signal into a reported value, and the software that hosts the model, for the process step and product named in the header. It does not cover the instrument’s basic hardware IQ/OQ (wavelength accuracy, photometric linearity, noise), which is qualified under <<FILL: instrument IQ/OQ protocol ID>> and referenced as a prerequisite.

3. System description

FieldEntry
Process step monitored<<FILL: e.g. fluid-bed drying endpoint>>
Measured attribute<<FILL: e.g. percent moisture>>
Sensor / probe technology<<FILL: e.g. NIR, Raman, focused-beam reflectance>>
Model type<<FILL: e.g. PLS regression, N latent variables>>
Preprocessing applied<<FILL: e.g. second-derivative, SNV scatter correction>>
Host software / platform<<FILL: name and version>>
Reference method it is validated against<<FILL: e.g. USP loss-on-drying, gravimetric method ID>>
Intended use<<FILL: in-process control only / RTRT replacing a specified lab test>>

4. Prerequisites

  1. Instrument hardware IQ/OQ complete and current (<<FILL: protocol ID>>).
  2. Reference method qualified or validated and currently in routine use.
  3. Calibration (training) data set assembled, spanning the full intended operating range including worst-case edges, with each point’s reference-method result recorded.
  4. Model built and frozen under version control before this protocol executes; the version under test is recorded in section 3 and cannot change during execution without a protocol deviation.

5. Roles and responsibilities

RoleResponsibility
Process engineering / PAT leadBuilds and documents the model; executes test cases; investigates any out-of-criteria result.
Analytical / QC leadGenerates and confirms reference-method results used for comparison; confirms the reference method’s own validity for this comparison.
ValidationAuthors and executes the protocol; confirms negative-path test design; compiles the summary report.
Quality AssuranceReviews and approves the protocol and the final report; approves the model version for GxP use.

6. Acceptance criteria

ParameterAcceptance criterion
Accuracy (bias vs. reference method)<<FILL: e.g. mean bias within +/- 0.1% across the calibration range>>
Precision (repeatability)<<FILL: e.g. RSD <= X% on replicate readings of the same sample>>
Precision (intermediate, different operator/day)<<FILL: e.g. RSD <= X%>>
SpecificityModel is not materially affected by <<FILL: named interferent, e.g. particle-size variation>> within the range tested
Equivalence to reference method<<FILL: e.g. linear regression slope 0.9-1.1, intercept not significantly different from zero, correlation coefficient >= 0.98 across N >= paired samples>>
Applicability domain enforcementEvery spectrum or reading outside the defined domain is flagged and routed to a hold, not silently accepted or extrapolated
Negative-path detectionEvery seeded failure (fouled probe, out-of-range material, wrong material) is detected and flagged in 100% of challenges

7. Test cases

IDStepExpected resultActual resultPass/FailTesterDate
TC-01Run the full calibration set through the frozen model and compare predicted values to reference-method results across the rangeAccuracy and precision criteria in section 6 met<<FILL>><<FILL>><<FILL>><<FILL>>
TC-02Run paired samples (PAT reading vs. reference method) at the low, mid, and high end of the operating range, N replicates eachEquivalence criteria in section 6 met at each level<<FILL>><<FILL>><<FILL>><<FILL>>
TC-03Introduce a known interferent <<FILL>> at a realistic level and confirm the model’s prediction does not shift beyond the specificity criterionSpecificity criterion met<<FILL>><<FILL>><<FILL>><<FILL>>
TC-04Present a spectrum from a different, unrelated material or an intentionally fouled probe readingSystem flags the reading as outside the applicability domain and does not report a disposition value<<FILL>><<FILL>><<FILL>><<FILL>>
TC-05Present a reading just outside the upper and lower edges of the calibrated rangeBoth are flagged, not extrapolated and silently accepted<<FILL>><<FILL>><<FILL>><<FILL>>
TC-06Confirm raw spectral/sensor data is retained and retrievable for every reading in TC-01 through TC-05100% of raw data retrievable and linked to its prediction<<FILL>><<FILL>><<FILL>><<FILL>>
TC-07Confirm the model version identifier is recorded against every reading generated during this protocolVersion identifier present and matches section 3 for every reading<<FILL>><<FILL>><<FILL>><<FILL>>

8. Deviation handling

Record any unexpected result, including a test case that passes but shows a borderline value, on a protocol deviation form referencing this protocol number. Assess impact on every prior test case before continuing. A failure in TC-04 or TC-05 (the applicability-domain checks) blocks approval until the detection logic is corrected and the test case re-executed; it is not waivable by a risk assessment, because an undetected out-of-domain reading is the specific failure mode this protocol exists to rule out.

9. Summary and conclusion

FieldEntry
Overall result<<FILL: Pass / Pass with documented deviations / Fail>>
Model version qualified<<FILL>>
Intended use approved<<FILL: in-process control only, or RTRT replacing SPECIFIC LAB TEST>>
Ongoing verification schedule set<<FILL: frequency and method, cross-reference to the monitoring SOP>>
Conclusion narrative<<FILL>>

10. Attachments

  • Calibration (training) data set and reference-method results.
  • Raw spectra/sensor files for every test case run.
  • Model build and preprocessing documentation.
  • Any deviation records raised during execution.

11. References

ICH Q13, Continuous Manufacturing of Drug Substances and Drug Products. ICH Q14, Analytical Procedure Development. ICH Q8(R2), Pharmaceutical Development (design space). USP General Chapter <1039>, Chemometrics. FDA guidance for industry, PAT, a Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance (2004). 21 CFR 211.110, Sampling and testing of in-process materials and drug products.

Confirm the current version and clause numbers of each reference before issue.


Filled specimen (excerpt)

A film-coating process uses an NIR probe to predict percent coating weight gain, intended to replace the end-of-run gravimetric weight-gain check.

FieldEntry
Process step monitoredTablet film coating, in-process weight gain
Measured attributePercent coating weight gain
Sensor / probe technologyNIR, in-line probe
Model typePLS regression, 4 latent variables
Reference methodGravimetric weight-gain determination, Method QC-114
Intended useRTRT, replacing the end-of-run gravimetric check for routine batches
IDExpected resultActual resultPass/Fail
TC-01Bias within +/- 0.1%, RSD <= 3%Bias 0.04%, RSD 1.8%Pass
TC-02Slope 0.9-1.1, r >= 0.98, N=36 pairsSlope 1.02, r = 0.993Pass
TC-04Fouled-probe reading flagged, no value reportedFlagged as “signal quality fail,” no disposition value generatedPass

Conclusion: model version NIR-CM-2026-03 qualified for RTRT use replacing Method QC-114 for routine batches; ongoing verification set at 1-in-10 batches against the gravimetric method for the first six months, then re-assessed.

Common inspection findings this protocol prevents

  • A PAT model used for disposition with no documented accuracy, precision, or equivalence data against the reference method it replaces.
  • No defined applicability domain, so an out-of-range or anomalous reading is silently extrapolated into a confident but invalid result.
  • Raw spectral data discarded once the predicted value is stored, leaving no way to reprocess a disputed result.
  • Model version not recorded against individual readings, so a later retrain cannot be traced back to which batches it decided.

How to adapt this protocol

  1. Set your acceptance criteria in section 6 from your own process capability and the risk of the decision the model supports; do not copy another product’s numbers.
  2. Size the calibration and paired-comparison data sets to the statistical power you need; consult a statistician for the regression and equivalence testing approach.
  3. If the model will support RTRT replacing a specific laboratory test, name that test explicitly in sections 1 and 3, and keep the reference method running in parallel per your ongoing verification schedule after go-live.
  4. Link this protocol to your model-monitoring SOP so the ongoing verification frequency set in section 9 is actually executed after qualification.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.